116 related articles for article (PubMed ID: 3928502)
1. Efficacy of discontinuous flow centrifugation compared with cascade filtration in Waldenstrom's macroglobulinemia: a pilot study.
Valbonesi M; Montani F; Guzzini F; Angelini G; Florio G
Int J Artif Organs; 1985 May; 8(3):165-8. PubMed ID: 3928502
[TBL] [Abstract][Full Text] [Related]
2. Hyperviscosity syndrome: efficacy and comparison of plasma exchange by plasma separation and cascade filtration in patients with immunocytoma of Waldenström's type.
Höffkes HG; Heemann UW; Teschendorf C; Uppenkamp M; Philipp T
Clin Nephrol; 1995 May; 43(5):335-8. PubMed ID: 7634550
[TBL] [Abstract][Full Text] [Related]
3. Histidine based adsorbents for selective removal of monoclonal immunoglobulin IgM antibodies from Waldenstrom's macroglobulinemia patient sera: a preliminary study.
Srour M; Kassab I; Matta H; Elkak A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():1-5. PubMed ID: 23811496
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of therapeutic procedure for Waldenström's macroglobulinemia with hyperviscosity syndrome.
Ito K; Kawasaki T; Hirano K; Sekiguchi N
Ther Apher Dial; 2024 Jun; 28(3):417-423. PubMed ID: 38069574
[TBL] [Abstract][Full Text] [Related]
5. Different cascade filtration operating modalities in clinical use.
Busnach G; Dal Col A; Brando B; Cappelleri A; Perrino ML; Brunati C; Minetti L
Int J Artif Organs; 1988 Nov; 11(6):493-6. PubMed ID: 3144514
[TBL] [Abstract][Full Text] [Related]
6. [Alleviation of ocular complications of the hyperviscosity syndrome in Waldenström's macroglobulinemia using plasma exchange].
Malecaze F; Mathis A; Gonzales C; Lloveras JJ; Goudable C; Arlet P; Bec P
J Fr Ophtalmol; 1986; 9(5):367-71. PubMed ID: 3100607
[TBL] [Abstract][Full Text] [Related]
7. Plasma exchange in the long-term management of Waldenström's macroglobulinemia.
Buskard NA; Galton DA; Goldman JM; Kohner EM; Grindle CF; Newman DL; Twinn KW; Lowenthal RM
Can Med Assoc J; 1977 Jul; 117(2):135-7. PubMed ID: 406031
[TBL] [Abstract][Full Text] [Related]
8. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
[TBL] [Abstract][Full Text] [Related]
9. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia.
Menke MN; Feke GT; McMeel JW; Treon SP
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1157-60. PubMed ID: 18326744
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of fractionation characteristics in cascade filtration.
Busnach G; Mandelli E; Brando B; Brunati C
Int J Artif Organs; 1993 Dec; 16 Suppl 5():155-9. PubMed ID: 8013978
[TBL] [Abstract][Full Text] [Related]
11. Role of plasmapheresis in Waldenström's macroglobulinemia.
Stone MJ; Bogen SA
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):238-40. PubMed ID: 23522642
[TBL] [Abstract][Full Text] [Related]
12. Hyperviscosity in plasma cell dyscrasias.
Kwaan HC
Clin Hemorheol Microcirc; 2013; 55(1):75-83. PubMed ID: 23455837
[TBL] [Abstract][Full Text] [Related]
13. Ophthalmologic techniques to assess the severity of hyperviscosity syndrome and the effect of plasmapheresis in patients with Waldenström's macroglobulinemia.
Menke MN; Feke GT; McMeel JW; Treon SP
Clin Lymphoma Myeloma; 2009 Mar; 9(1):100-3. PubMed ID: 19362987
[TBL] [Abstract][Full Text] [Related]
14. [Plasmapheresis in the treatment of waldenström's macroglobulinaemia (author's transl)].
Barbolla L; Fernández MN
Sangre (Barc); 1978; 23(3):334-42. PubMed ID: 97796
[No Abstract] [Full Text] [Related]
15. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
[TBL] [Abstract][Full Text] [Related]
16. Waldenstrom's macrogloblinaemia: modified plasmapheresis as treatment option in a Nigeria setting.
Abjah UM; Aken'Ova YA; Ocheni S
Niger J Med; 2002; 11(4):190-2. PubMed ID: 12955999
[TBL] [Abstract][Full Text] [Related]
17. Pleural effusion after plasmapheresis in Waldenström's macroglobulinemia.
Karlinsky J; Seder R; Corral R
Chest; 1986 Jan; 89(1):146-8. PubMed ID: 3079691
[TBL] [Abstract][Full Text] [Related]
18. [Effectiveness of plasmapheresis on the PF-0.5 blood separator in patients with paraproteinemic hemoblastoses].
Abdullaev OM; Postnikov AA; Prigozhina TA; Likhovetskaia ZM; Mokeeva RA
Ter Arkh; 1987; 59(10):77-81. PubMed ID: 2448887
[TBL] [Abstract][Full Text] [Related]
19. Plasmapheresis in hyperviscosity syndrome.
Avnstorp C; Nielsen H; Drachmann O; Hippe E
Acta Med Scand; 1985; 217(1):133-7. PubMed ID: 3919530
[TBL] [Abstract][Full Text] [Related]
20. Massive hollow fiber clotting: a distinct problem in treatment of cryoglobulinemia by membrane plasmapheresis.
Lai KN; Cheng SC; Vallance-Owen J
Artif Organs; 1987 Jun; 11(3):259-64. PubMed ID: 3113406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
